THAT in connection with the above, pursuant to Section 85 of the Act to be read together with Clause 58 of the Constitution of the Company, the shareholders do hereby waive the statutory pre-emptive rights of the offered shares in proportion of their holdings at such price and at such terms to be offered arising from any issuance of the new shares above by the Company.” 8. PROPOSED RENEWAL OF AUTHORITY FOR DIRECTORS TO ALLOT AND ISSUE NEW ZETRIX AI SHARES IN RELATION TO THE DIVIDEND REINVESTMENT PLAN (“DRP”) THAT PROVIDES SHAREHOLDERS WITH AN OPTION TO ELECT TO REINVEST THEIR CASH DIVIDEND IN ZETRIX AI SHARES “THAT pursuant to the DRP approved by the shareholders at the Extraordinary General Meeting held on 6 August 2020, approval be and is hereby given to the Company to allot and issue such number of new Zetrix AI Shares for the DRP until the conclusion of the 26th AGM, upon such terms and conditions and to such persons as the Directors may, in their absolute discretion, deem fit and in the interest of the Company PROVIDED THAT the issue price of the said new Zetrix AI Shares, shall be determined and fixed by the Board of Directors (“the Board”) at not more than ten percent (10%) discount to the 5-day volume weighted average market price (“VWAP”) of Zetrix AI Shares immediately preceding the price-fixing date, of which the VWAP shall be adjusted ex-dividend before applying the aforementioned discount in fixing the issue price at the material time; AND THAT the Board be and is hereby authorised to do all such acts and enter into all such transactions, arrangements, and documents as may be necessary or expedient in order to give full effect to the DRP with full power to assent to any conditions, modifications, variations and/or amendments (if any) as may be imposed or agreed to by any relevant authorities or consequent upon the implementation of the said conditions, modifications, variations and/or amendments, as the Board may, in its absolute discretion, deem fit and in the best interest of the Company.” Ordinary Resolution 8 9. To transact any other business that may be transacted at the 25th AGM of which due notice shall have been given in accordance with the Act and the Constitution of the Company. BY ORDER OF THE BOARD CHIN WAI YI (MAICSA 7069783) (SSM PC No. 202008004409) Company Secretary Kuala Lumpur Date: 30 April 2026 Explanatory Notes on Ordinary and Special Businesses: 1. Item 1 of the Agenda – Audited Financial Statements Agenda item no. 1 is meant for discussion only as the provisions of Section 340 of the Act does not require a formal approval of shareholders. Hence, this item on the Agenda is not put forward for voting. 2. Item 3 of the Agenda – Directors’ Fees and Benefits for the FY2025 Payment of Directors’ Fees and Benefits under Section 230(1) of the Act provides amongst others, that the Directors’ fees and any benefits payable to the Directors of the Company and its subsidiaries shall be approved at a general meeting. NOTICE OF TWENTY-FIFTH ANNUAL GENERAL MEETING (cont’d) 302
RkJQdWJsaXNoZXIy NDgzMzc=